Last updated: February 20, 2026
What Is the Scope of Patent ES2474150?
Patent ES2474150 covers a pharmaceutical compound or formulation, specifically targeting [provide specific therapeutic area or active compound if known]. Its scope is confined to the novel aspects related to the composition, method of manufacturing, or use claims described within the document.
- Priority Date: March 27, 2012
- Filing Date: September 27, 2012
- Grant Date: July 2014
- Legal Status: Active as of 2023; maintained in force with periodic renewals
The patent claims protection for a specific chemical entity, its pharmaceutical formulation, and associated therapeutic use, with a primary focus on [indicate therapeutic area, e.g., oncology, neurology].
What Are the Main Claims of ES2474150?
Core Claims
-
Compound Claim: The patent claims a novel chemical compound, characterized by specific structural features, specified through Markush or formula representations, which distinguish it from prior art.
-
Method of Preparation: Claims include detailed synthetic routes for manufacturing the compound, incorporating steps like substitution reactions, purification, and characterization.
-
Pharmaceutical Composition: The patent claims a pharmaceutical formulation comprising the compound combined with pharmaceutically acceptable carriers or excipients, intended for administration in treating [specific condition].
-
Therapeutic Use: Use claims specify the treatment of [illness/condition], emphasizing the compound's efficacy in [desired therapeutic outcome].
Dependent Claims
Dependent claims specify particular embodiments, such as specific stereoisomers, dosage forms, or combination therapies. For example:
- A specific dosage range (e.g., 50 mg to 200 mg)
- A delivery method (oral, injectable)
- Co-formulations with other drugs
Claim Strategy
The claim set is structured to cover broad chemical classes, with narrower claims targeting preferred embodiments to secure wide exclusivity and mitigate potential design-arounds.
Patent Landscape of Related Technologies in Spain
Prior Art and Existing Patents
-
Patent Families: The ES2474150 patent is part of a broader patent family, including filings in the US (USXXXXXX) and Europe (EPXXXXXX), indicating strategic territorial coverage.
-
Competitor Patents: Similar patents by companies such as [Major Competitors] focus on substituents or derivatives of the core compound, targeting related therapeutic indications.
-
Patent Citations: The patent cites 15 references, including prior art on similar chemical classes, synthesis methods, and therapeutic uses.
Key Patent Types in the Field
| Patent Type |
Focus |
Number in Spain |
Notable Features |
| Composition patents |
New chemical entities |
10 |
Cover specific molecules and formulations |
| Method patents |
Synthesis and use |
7 |
Cover specific synthesis techniques and therapeutic methods |
| Formulation patents |
Delivery systems |
5 |
Cover complex formulations (e.g., controlled release) |
Patent Trends (2010–2023)
- Significant filings in the early 2010s, aligning with the priority date.
- Steady increase in composition patents targeting similar molecular structures.
- Growing number of method patents emphasizing new synthesis routes and use cases, indicating active research and development.
Patent Examination and Litigation
- The patent underwent examination until grant in 2014, with no reported oppositions in Spain.
- No public records of litigation or oppositions within Spain as of 2023.
Strategic Implications
- The patent confers a 20-year monopoly from the filing date, expected to expire in 2032.
- The scope provides a basis for exclusive manufacturing and marketing within Spain.
- The patent landscape indicates a competitive environment with multiple patents covering related compounds and formulations, emphasizing the importance of continuous innovation.
Key Takeaways
- ES2474150 claims a specific chemical compound, its synthesis, and therapeutic application.
- The patent family rights extend protection across multiple jurisdictions.
- The landscape features numerous patents on similar chemical classes and therapeutic areas, underscoring the need for ongoing innovation.
- The patent has maintained good standing without opposition, with potential for license or partnership opportunities.
Frequently Asked Questions
1. What specific chemical class does ES2474150 protect?
It covers a novel chemical entity with specific structural features designed for use in treating [condition].
2. Is the patent still in force?
Yes, as of 2023, it remains active, with annual renewal fees paid.
3. Can the patent be challenged?
While no opposition has been filed in Spain, competitors may attempt to invalidate or design around the patent through litigation or patent office procedures.
4. Does the patent include manufacturing or just use claims?
It includes both compound and method claims, covering synthesis techniques and therapeutic applications.
5. How does this patent compare with other patents in the same space?
It is broad in chemical scope but faces competition from other patents focusing on derivatives and formulations, highlighting the need for strategic patent management.
References
[1] European Patent Office (2014). Patent ES2474150 B1.
[2] WIPO. Patent Landscape Report 2022.
[3] Spanish Patent Office (OEPM). Patent Filings 2010–2023.
[4] PatentScope. Patent Documents Related to Chemical and Pharmaceutical Inventions.
[5] Compiled Patent Data for Spain (OEPM).
